AC Immune SA (ACIU)

2.51 -0.15 (-5.64%) USD  |  NASDAQ  |  Sep 25, 16:00
2.51 0.00 (0.00%) After-Hours: 19:59
More

AC Immune Research and Development Expense (Annual) : 67.96M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for ACIU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Research and Development Expense (Annual) Data

View and export this data back to 2014. Start Trial.
Date Value
December 31, 2025 67.96M
December 31, 2024 71.05M
December 31, 2023 60.76M
December 31, 2022 63.17M
December 31, 2021 68.12M
December 31, 2020 63.38M
Date Value
December 31, 2019 50.75M
December 31, 2018 45.24M
December 31, 2017 32.60M
December 31, 2016 25.88M
December 31, 2015 17.41M
December 31, 2014 17.28M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Precigen, Inc. 40.06M
Basilea Pharmaceutica AG 127.51M
Santhera Pharmaceuticals Holding AG 26.75M
Aldeyra Therapeutics, Inc. 25.66M
BeOne Medicines Ltd. 2.079B